Skip to main content

Moderna, Inc. (NASDAQ: MRNA) Investor Securities Class Action Lawsuit 08/09/2024

  • If you purchased shares of Moderna, Inc. (NASDAQ: MRNA), you have certain options. NASDAQ: MRNA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

October 13, 2026 - The court dismissd the case with prejudice.  October 24, 2025 - The defendants filed their motion to dismiss the case. August 25, 2025 - an amended complaint was filed. August 09, 2024 - An investor in shares of Moderna, Inc. (NASDAQ: MRNA) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws...



You must register (for free) or login to view the entire case.